NCT06246409 Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
| NCT ID | NCT06246409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 650 participants |
| Start Date | 2024-12-24 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 650 participants in total. It began in 2024-12-24 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materials and measure whether the improvement in clarity and specificity produces the desired changes in patient decision-making and emotional comfort.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 18 years old planning their first external beam radiotherapy * Written informed consent obtained from the subject and the subject agrees to comply with all the study-related procedures. Exclusion Criteria: * Have received external beam radiotherapy in the past * External beam radiotherapy is initiated as inpatient. * External beam radiotherapy consists of less than 3 fractions. * Planned radiotherapy that does not employ an external beam * Planned participation in a clinical study that prohibits participation in a second, concurrent treatment trial * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.
Contact & Investigator
Alexandra De Leo, MD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT06246409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06246409 currently recruiting?
Yes, NCT06246409 is actively recruiting participants. Contact the research team at amy.carrao-tackett@ufhealth.org for enrollment information.
Where is the NCT06246409 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT06246409 clinical trial?
NCT06246409 is sponsored by University of Florida. The principal investigator is Alexandra De Leo, MD at University of Florida. The trial plans to enroll 650 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.